GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genomma Lab Internacional SAB de CV (MEX:LABB) » Definitions » EV-to-EBITDA

Genomma Lab InternacionalB de CV (MEX:LABB) EV-to-EBITDA : 7.16 (As of Jun. 25, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Genomma Lab InternacionalB de CV EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Genomma Lab InternacionalB de CV's enterprise value is MXN20,350 Mil. Genomma Lab InternacionalB de CV's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was MXN2,844 Mil. Therefore, Genomma Lab InternacionalB de CV's EV-to-EBITDA for today is 7.16.

The historical rank and industry rank for Genomma Lab InternacionalB de CV's EV-to-EBITDA or its related term are showing as below:

MEX:LABB' s EV-to-EBITDA Range Over the Past 10 Years
Min: -35.96   Med: 8.7   Max: 17.12
Current: 7.16

During the past 13 years, the highest EV-to-EBITDA of Genomma Lab InternacionalB de CV was 17.12. The lowest was -35.96. And the median was 8.70.

MEX:LABB's EV-to-EBITDA is ranked better than
78.45% of 710 companies
in the Drug Manufacturers industry
Industry Median: 13.815 vs MEX:LABB: 7.16

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-25), Genomma Lab InternacionalB de CV's stock price is MXN16.63. Genomma Lab InternacionalB de CV's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was MXN1.112. Therefore, Genomma Lab InternacionalB de CV's PE Ratio for today is 14.96.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Genomma Lab InternacionalB de CV EV-to-EBITDA Historical Data

The historical data trend for Genomma Lab InternacionalB de CV's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomma Lab InternacionalB de CV EV-to-EBITDA Chart

Genomma Lab InternacionalB de CV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.51 8.46 9.27 7.05 6.48

Genomma Lab InternacionalB de CV Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.02 5.52 5.40 6.48 7.02

Competitive Comparison of Genomma Lab InternacionalB de CV's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Genomma Lab InternacionalB de CV's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genomma Lab InternacionalB de CV's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Genomma Lab InternacionalB de CV's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Genomma Lab InternacionalB de CV's EV-to-EBITDA falls into.



Genomma Lab InternacionalB de CV EV-to-EBITDA Calculation

Genomma Lab InternacionalB de CV's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=20349.940/2843.509
=7.16

Genomma Lab InternacionalB de CV's current Enterprise Value is MXN20,350 Mil.
Genomma Lab InternacionalB de CV's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN2,844 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genomma Lab InternacionalB de CV  (MEX:LABB) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Genomma Lab InternacionalB de CV's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=16.63/1.112
=14.96

Genomma Lab InternacionalB de CV's share price for today is MXN16.63.
Genomma Lab InternacionalB de CV's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN1.112.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Genomma Lab InternacionalB de CV EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Genomma Lab InternacionalB de CV's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Genomma Lab InternacionalB de CV (MEX:LABB) Business Description

Traded in Other Exchanges
Address
Avenida Antonio Dovalí Jaime, Number 70, Tower C, Floor 2, Office A. Colonia Santa Fe, Del. Alvaro Obregon, Mexico, MEX, MEX, CP 01210
Genomma Lab Internacional SAB de CV is a specialty and generic drug manufacturer. The company's stated goal is to improve and preserve the health and well-being of people through innovative, safe, and effective products. Genomma operates a wide variety of brands to serve different consumer needs, including pregnancy, pain medication, and deodorant. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Genomma Lab InternacionalB de CV (MEX:LABB) Headlines

No Headlines